Coronavirus disease 2019 and obstructive sleep apnea syndrome
Yazarlar (3)
Prof. Dr. Ahmet Cemal PAZARLI
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Türkmenbaşı Medical Center, Türkiye
Medicana Hospital, Türkiye
| Makale Türü |
Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği,
araştırma notu, bilirkişi raporu ve benzeri)
|
| Makale Alt Türü | SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale |
| Dergi Adı | Sleep and Breathing |
| Dergi ISSN | 1520-9512 Wos Dergi Scopus Dergi |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Dergi Grubu | Q3 |
| Makale Dili | İngilizce |
| Basım Tarihi | 05-2021 |
| Cilt No | 25 |
| Sayı | 1 |
| Sayfalar | 371 / 371 |
| DOI Numarası | 10.1007/s11325-020-02087-0 |
| Makale Linki | http://dx.doi.org/10.1007/s11325-020-02087-0 |
| Özet |
| Dear Editor The publications regarding the continuing of pandemic coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing. Increased age, hypertension, cardiovascular diseases, lung diseases, and diabetes mellitus seem to be the main risk factors for mortality in COVID-19 [1]. However, the possible association between obstructive sleep apnea syndrome (OSAS), repetitive airway collapse with apnea/hypopnea and hypoxia during sleep, and COVID-19 has not been reported yet. Angiotensin converting enzyme 2 (ACE2) is the entry receptor of SARS-CoV-2 [2]. Of note, the increased expression of ACE and dysregulation of renin angiotensin system in untreated OSAS patients due to chronic intermittent hypoxia has been shown [3]. Furthermore, cardiovascular complications or comorbidities such as hypertension, heart failure, coronary … |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| WoS | 21 |
| SCOPUS | 25 |
| Google Scholar | 45 |